Mankind Pharma acquires Bharat Serums and Vaccines for Rs 13,768 Cr

Quick Summary:

Bharat Serums and Vaccines has developed recombinant and niche biologic products in-house, demonstrating strong R&D capabilities.

It has a branded product portfolio across women's health, fertility, critical care and immunoglobulins.

In July this year, Mankind had announced that it will acquire 100% stake in BSV.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Press Trust of India

Category: StartupsEconomyBusiness

Markets: India

Topics: Pharma Health Vaccines Developed Policy Fertility Serums Products Privacy Mankind

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-24 @ 05:18:41 (1 weeks ago)

News Timezone: GMT +8:00

News Source URL: yourstory.com

Language: English

Article Length: 227 words

Reading Time: 2 minutes read

Sentences: 18 lines

Sentence Length: 13 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © YourStory

News ID: 23220038

View Article Analysis

About YourStory

Main Topics: StartupsEconomyBusiness

Official Website: yourstory.com

Update Frequency: 7 posts per day

Year Established: 2008

Headquarters: India

News Last Updated: 9 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #44

Publisher Details

Frequently Asked Questions